Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

24432 ARTÍCULOS , VIENDO DEL 4891 AL 4905

Redefining oxidative stress in Alzheimer's disease: Targeting platelet reactive oxygen species for novel therapeutic options

Beura SK, Dhapola R, Panigrahi AR, Yadav P, Reddy DH, Singh SK.

Life Sci. 2022 Oct 1;306:120855. doi: 10.1016/j.lfs.2022.120855. Epub 2022 Aug 1.

Brain aging, Alzheimer's disease, and the role of stem cells in primate comparative studies

August I, Semendeferi K, Marchetto MC.

J Comp Neurol. 2022 Dec;530(17):2940-2953. doi: 10.1002/cne.25394. Epub 2022 Aug 5.

Kaempferol as a potential neuroprotector in Alzheimer's disease

Nejabati HR, Roshangar L.

J Food Biochem. 2022 Dec;46(12):e14375. doi: 10.1111/jfbc.14375. Epub 2022 Aug 5.

Serine Racemase Expression Differentiates Aging from Alzheimer's Brain

Wu S, Zhou J, Zhang H, Barger SW.

Curr Alzheimer Res. 2022;19(7):494-502. doi: 10.2174/1567205019666220805105106.

Dendrimers: A Neuroprotective Lead in Alzheimer Disease: A Review on its Synthetic approach and Applications

Singh A, Ansari VA, Mahmood T, Ahsan F, Wasim R.

Drug Res (Stuttg). 2022 Oct;72(8):417-423. doi: 10.1055/a-1886-3208. Epub 2022 Aug 5.

Review: Investigating the aggregation of amyloid beta with surface plasmon resonance: Do different approaches yield different results?

Young KA, Mancera RL.

Anal Biochem. 2022 Oct 1;654:114828. doi: 10.1016/j.ab.2022.114828. Epub 2022 Aug 2.

Neuropathologic Changes Provide Insights into Key Mechanisms of Alzheimer Disease and Related Dementia

Plascencia-Villa G, Perry G.

Am J Pathol. 2022 Oct;192(10):1340-1346. doi: 10.1016/j.ajpath.2022.07.002. Epub 2022 Aug 2.

Alzheimer's Disease: Effects on brain circuits and synapses

Ch'ng TH, Augustine GJ.

Semin Cell Dev Biol. 2023 Apr;139:1-2. doi: 10.1016/j.semcdb.2022.08.002. Epub 2022 Aug 2.

Alzheimer's disease failed clinical trials

Asher S, Priefer R.

Life Sci. 2022 Oct 1;306:120861. doi: 10.1016/j.lfs.2022.120861. Epub 2022 Aug 4.

Neuropathology in chronic traumatic encephalopathy: a systematic review of comparative post-mortem histology literature

Murray HC, Osterman C, Bell P, Vinnell L, Curtis MA.

Acta Neuropathol Commun. 2022 Aug 6;10(1):108. doi: 10.1186/s40478-022-01413-9.

Generation of human induced pluripotent stem cell lines SPPHIi003-A and SPPHIi004-A from two patients with sporadic Alzheimer's disease in Southwestern China

Chen L, Zhang J, Yang X, Wang S, Ye F.

Stem Cell Res. 2022 Oct;64:102876. doi: 10.1016/j.scr.2022.102876. Epub 2022 Jul 28.

Neuropsychological and Neuroanatomical Features of Patients with Behavioral/Dysexecutive Variant Alzheimer's Disease (AD): A Comparison to Behavioral Variant Frontotemporal Dementia and Amnestic AD Groups

Dominguez Perez S, Phillips JS, Norise C, Kinney NG, Vaddi P, Halpin A, Rascovsky K, Irwin DJ, McMillan CT, Xie L, Wisse LEM, Yushkevich PA, Kallogjeri D, Grossman M, Cousins KAQ.

J Alzheimers Dis. 2022;89(2):641-658. doi: 10.3233/JAD-215728.

Recommendations to address key recruitment challenges of Alzheimer's disease clinical trials

Langbaum JB, Zissimopoulos J, Au R, Bose N, Edgar CJ, Ehrenberg E, Fillit H, Hill CV, Hughes L, Irizarry M, Kremen S, Lakdawalla D, Lynn N, Malzbender K, Maruyama T, Massett HA, Patel D, Peneva D, Reiman EM, Romero K, Routledge C, Weiner MW, Weninger S, Aisen PS.

Alzheimers Dement. 2023 Feb;19(2):696-707. doi: 10.1002/alz.12737. Epub 2022 Aug 10.

The glymphatic system: implications for drugs for central nervous system diseases

Lohela TJ, Lilius TO, Nedergaard M.

Nat Rev Drug Discov. 2022 Oct;21(10):763-779. doi: 10.1038/s41573-022-00500-9. Epub 2022 Aug 10.

Interpreting the Clinical Implications of Drug-Target Mendelian Randomization Studies

Ference BA.

J Am Coll Cardiol. 2022 Aug 16;80(7):663-665. doi: 10.1016/j.jacc.2022.06.007.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias